Telemedicine Acceptance in IBD
Why study telemedicine acceptance in IBD?
Transparency Life Sciences, in collaboration with Genentech, a member of the Roche Group, is conducting a pilot study in patients with inflammatory bowel disease.
The primary objective of this pilot study is to evaluate the effectiveness and ease-of-use of telemonitoring technology and techniques in assessing standard clinical endpoints in IBD.
We are focused on new methods to include patients’ local gastroenterologists in the development and execution of a clinical trial.
We are also investigating the role of dietary intervention in a trial in IBD.
We are interested in learning which symptoms are most important to IBD patients, and how they think those symptoms can be monitored at home.
An Opportunity for Publication
This project's Protocol Builder was completed before the implementation of the TLS Reward System. Therefore no rewards have been given for this project.Protocol Builder Results
Here's what TLS users are saying:
- Telemedicine started to revolutionize clinical research, so it is very timely to apply to IBD.
- It is very interesting to have potentially more real time data and even a researcher database.
- I think that virtual modality tools are underutilized, and have the potential to allow efficacy trials to translate to effectiveness research.
By describing their most meaningful symptoms, patients are helping us tailor the study to collect data on the aspects of IBD that are most pertinent to them.
Do you agree with the general reasoning behind using telemedicine techniques and devices in a study of IBD?
We've found that all researchers agree that prior participation in a clinical trial does affect a patient's ability to participate in a trial that focuses on telemedicine use and acceptance.
Some telemedicine solutions that patients and researchers have recommended are:
- Symptom tracking smartphone apps
- Stool sample photography
- Video conference links between patients and trial staff
What experience do you have with telemedicine, and how do you envision IBD symptoms being assessed remotely?
Do you have prior experience using telemedicine, and what are your ideas for remote assessment?
Local GI Participation
- Patients and medical professionals have both expressed a desire to use electronic communication to conduct aspects of the trial.
- Many patients have stressed the possibility of email and video technology providing greater access to physicians.
- Clinicians have stressed how the same email and video technology can help make communicating with patients easier and more amenable to a doctor's schedule.
- Patients and researchers both believe that telemedicine can increase the safety of an IBD clinical trial.
- Most clinicians are confident in recommending a remote trial of telemedicine in IBD to their patients.
We have not come to a consensus on the study's monitoring plan. Please share your ideas.
Here are some researchers' responses:
- Use a web-based data platform that allows entry of data from all involved in the trial
- Password protected portal availability to researchers and patients alike
Please discuss the data visualization plan in the forum by clinking the "Comments" button below.
We aim at making real life data available for all to see and understand. The only exceptions will be individual identification of patients and data which may lead to unblinding of the study, if applicable.